Cross-fund · 6 holders
ACAD
ACADIA PHARMACEUTICALS INC
CUSIP 004225108
6
Tracked holders
$976.0M
Aggregate value
40,816,127
Shares
6
Active funds
Funds holding ACAD
| Fund | Strategy | Period | Value | % of book | Δ shares | Status |
|---|---|---|---|---|---|---|
| BlackRock | Institutional | Q1 2026 | $479.7M | 0.01% | +795,469 | +3.8% |
| Vanguard | Institutional | Q4 2025 | $404.8M | 0.01% | -25,414 | -0.2% |
| Point72FEAT | Multi-Strategy | Q1 2026 | $58.0M | 0.07% | -771,995 | -22.9% |
| Millennium | Multi-Strategy | Q1 2026 | $15.7M | 0.01% | +151,787 | +27.4% |
| Citadel | Multi-Strategy | Q1 2026 | $14.7M | — | -746,799 | -53.1% |
| BridgewaterFEAT | Macro | Q1 2026 | $3.2M | 0.01% | +3,633 | +2.6% |
Aggregated from the latest 13F-HR per tracked fund (longs only). QoQ deltas compare against each fund's prior quarterly filing.